NEW PEPTIDE-BASED CANCER VACCINE: PHASE I AND EARLY PHASE II CLINICAL TRIALS FOR CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Noguchi, M. [1 ,2 ]
Suekane, S. [2 ]
Moriya, F. [2 ]
Sasada, T. [3 ]
Yamada, A. [3 ]
Itoh, K. [3 ]
机构：
[1] Kurume Univ, Sch Med, Res Ctr Innovat Canc Therapy, Div Clin Res, Kurume, Fukuoka 830, Japan
[2] Kurume Univ, Sch Med, Dept Urol, Kurume, Fukuoka 830, Japan
[3] Kurume Univ, Sch Med, Dept Immunol & Immunotherapy, Kurume, Fukuoka 830, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [31] Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial
    Filaci, Gilberto
    Fenoglio, Daniela
    Nole, Franco
    Zanardi, Elisa
    Tomasello, Laura
    Aglietta, Massimo
    Del Conte, Gianluca
    Carles, Joan
    Morales-Barrera, Rafael
    Guglielmini, Pamela
    Scagliotti, Giorgio
    Signori, Alessio
    Parodi, Alessia
    Kalli, Francesca
    Astone, Giuseppina
    Ferrera, Francesca
    Altosole, Tiziana
    Lamperti, Giuseppina
    Criscuolo, Domenico
    Gianese, Francesco
    Boccardo, Francesco
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (12) : 3679 - 3692
  • [32] Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial
    Gilberto Filaci
    Daniela Fenoglio
    Franco Nolè
    Elisa Zanardi
    Laura Tomasello
    Massimo Aglietta
    Gianluca Del Conte
    Joan Carles
    Rafael Morales-Barrera
    Pamela Guglielmini
    Giorgio Scagliotti
    Alessio Signori
    Alessia Parodi
    Francesca Kalli
    Giuseppina Astone
    Francesca Ferrera
    Tiziana Altosole
    Giuseppina Lamperti
    Domenico Criscuolo
    Francesco Gianese
    Francesco Boccardo
    Cancer Immunology, Immunotherapy, 2021, 70 : 3679 - 3692
  • [33] Phase II cohort study in patients with metastatic castration-resistant prostate cancer (mCRPC) with new cohorts
    Rexer, Heidrun
    Retz, Margitta
    Hammerer, Peter
    AKTUELLE UROLOGIE, 2022, 53 (06) : 504 - 505
  • [34] Phase II proof-of-concept study of atorvastatin in castration-resistant prostate cancer
    Rushworth, Linda K.
    Loveridge, Carolyn
    Salji, Mark
    MacLeod, Martin
    Mui, Ernest
    Sumpton, David
    Neilson, Matthew
    Hedley, Ann
    Alexander, Laura
    McCartney, Elaine
    Patel, Rachana
    Wallace, Jan
    Delles, Christian
    Jones, Rob
    Leung, Hing Y.
    BJU INTERNATIONAL, 2023, 131 (02) : 236 - 243
  • [35] Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer
    Nakabayashi, Mari
    Werner, Lilian
    Courtney, Kevin D.
    Buckle, Geoffrey
    Oh, William K.
    Bubley, Glen J.
    Hayes, Julia H.
    Weckstein, Douglas
    Elfiky, Aymen
    Sims, Danny M.
    Kantoff, Philip W.
    Taplin, Mary-Ellen
    BJU INTERNATIONAL, 2012, 110 (11) : 1729 - 1735
  • [36] Docetaxel and curcuminoids combination in patients with castration-resistant prostate cancer: A phase II study
    Mahammedi, H.
    Pouget, M.
    Planchat, E.
    Cure, H.
    Durando, X.
    Van-Praagh, I.
    Savareux, L.
    Abrial, C.
    Chollet, P.
    Eymard, J. C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S696 - S696
  • [37] Encouraging activity of bicalutamide and everolimus in castration-resistant prostate cancer (CRPC): Early results from a phase II clinical trial
    Pan, C.
    Ghosh, P.
    Lara, P., Jr.
    Robles, D.
    Beckett, L.
    White, R. de Vere
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [38] Phase I results of exicorilant plus enzalutamide in patients with castration-resistant prostate cancer
    Linch, M.
    Liu, G.
    Crabb, S. J.
    Beer, T. M.
    Heath, E.
    Gordon, M.
    de Bono, J. S.
    Pashova, H. I.
    Tudor, I. C.
    Custodio, J. M.
    Mann, G.
    Morris, M. J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1183 - S1183
  • [39] A PHASE II PROSPECTIVE STUDY OF KETOCONAZOLE IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS (CRPC)
    Verzoni, E.
    Bajetta, E.
    Giganti, M. O.
    Guadalupi, V.
    Capone, F.
    Donegani, S.
    Nicolai, N.
    Salvioni, R.
    Valdagni, R.
    Procopio, G.
    ANNALS OF ONCOLOGY, 2010, 21 : 278 - 278
  • [40] A PHASE II PROSPECTIVE STUDY OF KETOCONAZOLE IN CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS
    Guadalupi, V.
    Giganti, M. O.
    Testa, I.
    Villa, S.
    Nicolai, N.
    Biasoni, D.
    Salvioni, R.
    Valdagni, R.
    Bajetta, E.
    Procopio, G.
    ANTICANCER RESEARCH, 2010, 30 (04) : 1536 - 1536
12345